• ESPG published a joint market study with Colliers, flagging a shift in Germany’s life-science real estate market to a more selective phase.
• H1 2026 transaction volume reached about EUR 112 million, nearly matching full-year 2025, despite a lower post-2022 baseline.
• Investor demand pivoted toward core assets in established clusters; core represented about 83% of 2026 volume versus core-plus and development-led deals in 2020-2024.
• The report expects sustained demand for modern lab and R&D space, supported by long lease terms and lower work-from-home substitution risk.
• AI-driven “TechBio” shifts requirements toward more lab-IT integration; physical labs remain essential, with CROs taking a larger share of standardized research work.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ESPG AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2366612_de) on July 16, 2026, and is solely responsible for the information contained therein.